We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
-3.26%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$1.67B
AUM Growth
+$134M
Cap. Flow
+$180M
Cap. Flow %
10.83%
Top 10 Hldgs %
42.41%
Holding
98
New
25
Increased
27
Reduced
17
Closed
21

Top Buys

Rank Stock Value
1
CLVS
Clovis Oncology, Inc.
CLVS
+$39.2M
2
UTHR icon
United Therapeutics
UTHR
+$36.1M
3
CAR icon
Avis
CAR
+$33.4M
4
ENTA icon
Enanta Pharmaceuticals
ENTA
+$33.3M
5
RL icon
Ralph Lauren
RL
+$29M

Top Sells

Rank Stock Value
1
SGI
Somnigroup International
SGI
+$40.4M
2
PRKS icon
United Parks & Resorts
PRKS
+$34.4M
3
INCY icon
Incyte
INCY
+$29.4M
4
CVS icon
CVS Health
CVS
+$28.6M
5
VNDA icon
Vanda Pharmaceuticals
VNDA
+$27M

Sector Composition

Rank Sector Weight
1 Healthcare 37.02%
2 Consumer Discretionary 19.39%
3 Consumer Staples 7.59%
4 Industrials 2.26%
5 Communication Services 0.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACHN
51
DELISTED
Achillion Pharmaceuticals
ACHN
$7.36M 0.44%
2,000,000
-2,000,000
-50% -$5.96M
ALIM
52
DELISTED
Alimera Sciences
ALIM
$6.8M 0.41%
462,400
– –
CPRX
53
DELISTED
Catalyst Pharmaceutical
CPRX
$6.32M 0.38%
1,672,000
-28,000
-2% -$87.7K
FRTX
54
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$5.97M 0.36%
13,843
– –
NVLN
55
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$5.49M 0.33%
1,856,000
– –
FTCH
56
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
$5.45M 0.33%
+200,000
New +$5.66M
MED icon
57
Medifast
MED
$110M
$5.32M 0.32%
+24,000
New +$4.87M
SGI
58
Somnigroup International
SGI
$14.1B
$5.29M 0.32%
400,000
-3,024,000
-88% -$40.4M
KPRX icon
59
Kiora Pharmaceuticals
KPRX
$11.3M
$5.21M 0.31%
3,112
– –
APRN
60
CALL
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
$5.16M 0.31%
+16,667
New +$7.3M
CMRX
61
DELISTED
Chimerix, Inc.
CMRX
$5.06M 0.3%
1,300,000
+42,000
+3% +$179K
CENN icon
62
Cenntro
CENN
$8.09M
$4.92M 0.3%
2
– –
PDLI
63
DELISTED
PDL BioPharma, Inc.
PDLI
$4.73M 0.28%
+1,800,000
New +$4.42M
JCP
64
CALL
DELISTED
J.C. Penney Company, Inc.
JCP
$3.82M 0.23%
+2,300,000
New +$4.88M
T icon
65
AT&T
T
$158B
$3.36M 0.2%
+132,400
New +$3.24M
ORMP icon
66
Oramed Pharmaceuticals
ORMP
$169M
$3.04M 0.18%
+624,000
New +$3.24M
IPCI
67
DELISTED
Intellipharmaceuticals International Inc.
IPCI
$2.31M 0.14%
860,000
– –
FLNA
68
Filana Therapeutics
FLNA
$46.4M
$2.19M 0.13%
+2,164,000
New +$3.29M
DYNT
69
DELISTED
Dynatronics Corp
DYNT
$1.57M 0.09%
110,209
+1,926
+2% +$28K
SEEL
70
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$1.43M 0.09%
+40
New +$1.47M
TRAW icon
71
Traws Pharma
TRAW
$6.85M
$816K 0.05%
297
-3
-1% -$7.65K
VXRT
72
DELISTED
Vaxart
VXRT
$428K 0.03%
150,000
+72,401
+93% +$220K
AIXC
73
AIxCrypto Holdings Inc
AIXC
$13.2M
$339K 0.02%
15
+14
+1,400% +$363K
ROX
74
DELISTED
Castle Brands, Inc.
ROX
$107K 0.01%
+100,000
New +$114K
CTXR icon
75
Citius Pharmaceuticals
CTXR
$16.9M
$100K 0.01%
+2,337
New +$112K
1 2
3
4

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
DCP
DSM Capital Partners Palm Beach Gardens, Florida $5.66B AUM 27.45% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return

Armistice Capital's Q3 2018 Portfolio in Review

As of Q3 2018, Armistice Capital held 98 positions worth $1.67B, up 8.8% from $1.53B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Armistice Capital deployed $180M of net new capital in Q3 2018, opening 25 new positions and adding to 27 existing holdings. Its largest new stake was United Therapeutics: 292,000 shares worth $37.3M.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, down from 38% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

On the sell side, the largest reduction was Somnigroup International, an estimated $40.4M trimmed.

  • Armistice Capital's largest Q3 2018 buy was United Therapeutics: 292,000 shares worth $37.3M.
  • Armistice Capital added most to Clovis Oncology, Inc. in Q3 2018, an estimated $39.2M increase.
  • Armistice Capital's biggest Q3 2018 reduction was Somnigroup International, cutting an estimated $40.4M.
  • Armistice Capital fully exited United Parks & Resorts in Q3 2018, selling an estimated $34.4M.
  • Armistice Capital's ten largest holdings make up 42% of its $1.67B portfolio in Q3 2018.
  • Armistice Capital opened 25 new positions and closed 21 in Q3 2018.
  • Armistice Capital's portfolio value rose 8.8% quarter-over-quarter to $1.67B.

Based on Armistice Capital's 13F filing for Q3 2018, filed 14 Nov 2018.